We therefore incorporated a number of these biomarkers into a putative panel used to diagnose myocardial infarction: troponin T (TNNT2), fatty acid‐binding protein (FABPH), creatine kinase M type (KCRM), L‐lactate dehydrogenase (A and B chain), and cardiac myosin‐binding protein C3 (MYPC3) [26]. The gene discussed is TNNT2; the disease is myocardial infarction.